PURPOSE: To demonstrate the presence of endothelial dysfunction (ED) in asymptomatic patients with type 2 diabetes mellitus (DM) by using (13)N-ammonia-positron emission tomography (PET). PET can identify ED by quantifying myocardial blood flow (MBF) during rest, cold pressor test (CPT), and pharmacologic stress. The endothelial-dependent vasodilation index (EDVI), myocardial flow reserve (MFR), and the percentage of the change between rest and CPT (%DeltaMBF) are markers of endothelial function. PROCEDURES: Thirty-nine subjects were studied (19 women and 20 men); 22 recently diagnosed type 2 diabetic patients and 17 healthy controls (HC). A three-phase (13)N-ammonia-PET was performed. RESULTS: Mean EDVI was 1.208 +/- 0.34 vs. 1.55 +/- 0.37 (diabetic vs. HC group, respectively) (p = 0.002), MFR was 2.803 +/- 1.39 vs. 3.27 +/- 0.72 (p = NS), and the %DeltaMBF was 20 +/- 34% vs. 55 +/- 37% (p = 0.002). Rest MBF and CPT MBF were normalized to the rate pressure product (RPP). EDVI' and %DeltaMBF' were calculated using the corrected values for the RPP. Mean EDVI' was (0.864 +/- 0.250 vs. 1.110 +/- 0.238, p = 0.004) and mean %DeltaMBF' was (-8.2 +/- 14.7% vs. 4.5 +/- 12.1%, p = 0.005). CONCLUSIONS: Asymptomatic, recently diagnosed type 2 diabetes patients present ED that can be quantified by (13)N-ammonia-PET.
PURPOSE: To demonstrate the presence of endothelial dysfunction (ED) in asymptomatic patients with type 2 diabetes mellitus (DM) by using (13)N-ammonia-positron emission tomography (PET). PET can identify ED by quantifying myocardial blood flow (MBF) during rest, cold pressor test (CPT), and pharmacologic stress. The endothelial-dependent vasodilation index (EDVI), myocardial flow reserve (MFR), and the percentage of the change between rest and CPT (%DeltaMBF) are markers of endothelial function. PROCEDURES: Thirty-nine subjects were studied (19 women and 20 men); 22 recently diagnosed type 2 diabeticpatients and 17 healthy controls (HC). A three-phase (13)N-ammonia-PET was performed. RESULTS: Mean EDVI was 1.208 +/- 0.34 vs. 1.55 +/- 0.37 (diabetic vs. HC group, respectively) (p = 0.002), MFR was 2.803 +/- 1.39 vs. 3.27 +/- 0.72 (p = NS), and the %DeltaMBF was 20 +/- 34% vs. 55 +/- 37% (p = 0.002). Rest MBF and CPT MBF were normalized to the rate pressure product (RPP). EDVI' and %DeltaMBF' were calculated using the corrected values for the RPP. Mean EDVI' was (0.864 +/- 0.250 vs. 1.110 +/- 0.238, p = 0.004) and mean %DeltaMBF' was (-8.2 +/- 14.7% vs. 4.5 +/- 12.1%, p = 0.005). CONCLUSIONS: Asymptomatic, recently diagnosed type 2 diabetespatients present ED that can be quantified by (13)N-ammonia-PET.
Authors: W G Kuhle; G Porenta; S C Huang; D Buxton; S S Gambhir; H Hansen; M E Phelps; H R Schelbert Journal: Circulation Date: 1992-09 Impact factor: 29.690
Authors: Mette M Madsen; Hanne M Søndergaard; Morten Bøttcher; Niels H Buus; Ole Schmitz; Hans E Bøtker; Torsten T Nielsen Journal: Diabetes Date: 2007-02 Impact factor: 9.461
Authors: M F Di Carli; D Bianco-Batlles; M E Landa; A Kazmers; H Groehn; O Muzik; G Grunberger Journal: Circulation Date: 1999-08-24 Impact factor: 29.690
Authors: J l Ritchie; T M Bateman; R O Bonow; M H Crawford; R J Gibbons; R J Hall; R A O'Rourke; A F Parisi; M S Verani Journal: Circulation Date: 1995-02-15 Impact factor: 29.690
Authors: Manuel J Quiñones; Miguel Hernandez-Pampaloni; Heinrich Schelbert; Isabel Bulnes-Enriquez; Xochitl Jimenez; Gustavo Hernandez; Roxana De La Rosa; Yun Chon; Huiying Yang; Susanne B Nicholas; Tamara Modilevsky; Katherine Yu; Katja Van Herle; Lawrence W Castellani; Robert Elashoff; Willa A Hsueh Journal: Ann Intern Med Date: 2004-05-04 Impact factor: 25.391
Authors: Maurice M Garcia; Thomas M Fandel; Guiting Lin; Alan W Shindel; Lia Banie; Ching-Shwun Lin; Tom F Lue Journal: J Sex Med Date: 2010-01 Impact factor: 3.802
Authors: Manoefris Kasim; Geoffrey M Currie; Markus Tjahjono; Bambang B Siswanto; Ganesja M Harimurti; Hosen Kiat Journal: Open Cardiovasc Med J Date: 2013-09-20
Authors: Weena J Y Chen; Michaela Diamant; Karin de Boer; Hendrik J Harms; Lourens F H J Robbers; Albert C van Rossum; Mark H H Kramer; Adriaan A Lammertsma; Paul Knaapen Journal: Cardiovasc Diabetol Date: 2017-05-19 Impact factor: 9.951